Diabetes and Endocrinology

  • If any of the following are present or suspected, please refer the patient to the emergency department (via ambulance if necessary) or follow local emergency care protocols or seek emergent medical advice if in a remote region.

    Adult conditions

    Hypertension

    • Hypertensive emergency (BP>220/120)
    • Severe hypertension (systolic BP >180) with any of the following concerning features:
      • headache
      • confusion
      • blurred vision
      • retinal haemorrhage
      • reduced level of consciousness
      • seizures
      • proteinuria
      • papilledema
      • signs of heart failure
      • chest pain
      • acute kidney injury
    • If suspected pregnancy induced hypertension or pre-eclampsia refer patient to the emergency department or maternity assessment unit of a facility that offers obstetric services where possible.
    • Phaeochromocytoma in crisis with uncontrolled hypertension

    Diabetes mellitus

    • Diabetes-related ketoacidosis
    • Diabetes and severe vomiting
    • Acute severe hyperglycaemia
    • Acute severe hypoglycaemia
    • Hyperosmolar hyperglycaemic state (HHS)
    • Foot ulcer with infection and systemically unwell or febrile
    • Invasive infection or rapidly spreading cellulitis of the foot (defined by peripheral redness around the wound >2cm)
    • Acute foot ischaemia
    • Wet gangrene foot
    • Newly diagnosed type 1 diabetes, please contact the on-call registrar or consultant immediately. The client should be referred to a diabetes specialist service within 24 hours. If a specialist service is not available, the client should present to the nearest emergency department.

    High Risk Foot

    • Foot ulcer with infection and systemically unwell or febrile
    • Invasive infection or rapidly spreading cellulitis (defined by peripheral redness around the wound >2cm)
    • Acute ischaemia
    • Wet gangrene
    • Acute or suspected acute Charcot foot unless able to access a High Risk Foot clinic within 48hours.

    Hyperthyroidism

    • Hyperthyroidism complicated by cardiac, respiratory compromise or other indications of severe illness (fever, vomiting, labile blood pressure, altered mental state)
    • Neutropenic sepsis in patient taking carbimazole or propylthiouracil
    • Hyperthyroidism with hypokalaemia or paralysis
    • Suspected myxoedema coma (altered consciousness, hypothermia, fluid overload, bradycardia, hyponatraemia)

    Insulinoma / hypoglycaemia unrelated to diabetes

    • Severe hypoglycaemia

    Obesity

    • Acute decompensation of cardiorespiratory/ renal function

    Adrenal disease

    • Addisonian crisis
    • Suspected or confirmed acute adrenal insufficiency

    Adrenal Mass

    • Severe hypertension (see above)
    • Phaeochromocytoma crisis
    • Potassium <3mmol/L
    • Suspected adrenal haemorrhage

    Pituitary disorders

    • Pituitary tumour with sudden severe headache
    • Acute onset visual loss or diplopia
    • Pituitary tumour with likely adrenal crisis (hypotension, tachycardia, vomiting, altered level of consciousness)

    Thyroid enlargement / thyroid nodules

    • Stridor associated with a thyroid mass
    • Possible tracheal or superior vena cava obstruction from retrosternal thyroid enlargement

    Oligo/amenorrhoea, hirsutism, acne, female infertility

    • Pituitary tumour with sudden severe headache, acute onset visual loss/diplopia or adrenal crisis (hypotension, tachycardia, vomiting, altered level of consciousness)

    Calcium, electrolyte and metabolic bone disorders

    • Hypokalaemia with potassium <3mmol/L
    • Acutely symptomatic hypocalcaemia (e.g. tetany) with serum corrected calcium <2.0mmol/L
    • Severe symptomatic hypercalcaemia (usually serum calcium > 3.0 mmol/l)
    • Hypernatraemia or hyponatraemia with acute confusion/delirium
    • Suspected or confirmed arginine vasopressin deficiency (previously known as central diabetes insipidus) or arginine vasopressin resistance (previously known as nephrogenic diabetes insipidus)  with hypernatraemia

    Paediatric Conditions

    Paediatric obesity

    • New diagnosis of type 1 diabetes = polyuria and/or polydipsia and random BSL >11.0.
    • Ketoacidosis in a person known to have diabetes with any of the following:
      • systemic symptoms (fever, lethargy) or
      • vomiting or
      • inability to eat (even if not vomiting) or
      • abdominal pain or
      • headache

    Paediatric diabetes

    • New diagnosis of type 1 diabetes = polyuria and/or polydipsia and random BSL >11.0.
    • Ketoacidosis in a known diabetic with any of the following:
      • systemic symptoms (fever, lethargy) or
      • vomiting or
      • inability to eat (even if not vomiting) or
      • abdominal pain or
      • headache

    Growth failure

    • Suspected pituitary mass (visual field loss/CNS signs)
    • Addisonian crisis (including unexplained hyponatraemia & hypoglycaemia)
    • Myxoedema coma
    • New onset diabetes insipidus (including unexplained hypernatraemia)
    • Hypocalcaemia (including acute rickets) with seizures
  • The following are not routinely provided in a public Diabetes and Endocrinology service.

    • Pre-diabetes
    • Stable, well-controlled type 2 diabetes
    • Newly diagnosed type 2 diabetes and not acutely unwell
    • Referrals where the primary problem requiring attention is not directly related to the diabetes and should be directed to another speciality service e.g. chest pain for investigation should go to cardiology
    • Dietary advice for weight reduction, high cholesterol, hypertension or CVD in patients with diabetes
    • Newly diagnosed primary hypothyroidism, including subclinical hypothyroidism – Note: in women of child bearing age who are pregnant or wishing to become pregnant or not using contraception, thyroxine should be commenced and titrated, aiming for a TSH less than 2.5
    • Positive thyroid antibodies with normal thyroid function
    • Osteopaenia
    • Routine uncomplicated osteoporosis
    • Gender Service exclusions:
      • Gender-affirming surgery
      • Ongoing medical management of GAHT
      • Mental health care
      • Psychiatric assessment for neurodevelopmental disorders, including for NDIS etc.

Last updated: 2 December 2024

© State of Queensland (Queensland Health) 2023

Except as permitted under the Copyright Act 1968, no part of this work may be reproduced, communicated or adapted without permission from Queensland Health. To request permission email ip_officer@health.qld.gov.au1.